Chinese chemical industry analyst Yang Yujun said the move was the first step in TPAHS’ “long-term vision to be an independent and independent, market-based supplier of organic chemicals.”
He said TPAHK would be “one of the first organic chemical companies to have an open sourcing strategy,” according to the official Xinhua news agency.TPAHK has more than 3,600 employees in the country, including 2,000 at its headquarters in Hangzhou, and has plans to expand to the rest of China, Yang said.
The company has been working on its products for more than two decades and has had several partnerships with chemical companies, including the first-ever joint venture in organic chemistry with the Chinese chemical company Tianjin Chemicals Group.
Its first product was the TPAHTECH, a carbon nanotube organic compound for chemical applications.
Treatments for a variety of ailments including psoriasis, psorocystis carinii and cystic fibrosis have also benefited from the compound.
Tens of thousands of TPAHRs were produced worldwide and sold for more $6 billion in 2014, according to an analysis by the International Organization for Standardization.
Treatment of psoradiosis was first developed by TPAHP as an alternative to chemotherapy and is a major contributor to the global supply chain, according the company.